2019 EVALI (Lung Injury) Emergency Response Series

Title:Update: Interim Guidance for Health Care Providers regarding the Management Approach of Patients with Suspected E-cigarette, or Vaping, Product Use-Associated Lung Injury (EVALI)

Date:Thursday, November 21, 2019

CDC, the U.S. Food and Drug Administration (FDA), state and local health departments, and public health and clinical stakeholders continue to investigate a national outbreak of electronic cigarette (e-cigarette), or vaping, product use–associated lung injury (EVALI).

EVALI remains a diagnosis of exclusion because, at present, no specific test or marker exists for its diagnosis, and evaluation should be guided by clinical judgment. Because patients with EVALI can present with symptoms similar to influenza or other respiratory infections (e.g., fever, cough, headache, myalgias, or fatigue), it might be difficult to differentiate EVALI from influenza or CAP (community-acquired pneumonia) on initial presentation, and EVALI may cooccur with respiratory infections. A large number of patients will be presenting to healthcare facilities with respiratory symptoms during the winter season who may not meet criteria for hospital admission, and this will be happening in the context of a national outbreak of EVALI.

During this COCA Call, U.S. health care providers will learn recommendations for managing patients with suspected or known EVALI when respiratory infections such as influenza are more prevalent in the community, as published in MMWR on November 19, 2019.

Presenters

CDR Mary (Molly) Evans, MD, MPH (USPHS)
Clinical Task Force Lead, 2019 CDC EVALI Response
Medical Officer, Division of Overdose Prevention
National Center for Injury Prevention and Control
Centers for Disease Control and Prevention

CAPT Timothy Uyeki, MD, MPH (USPHS)

Chief Medical Officer, Influenza Division
National Center for Immunization and Respiratory Diseases
Centers for Disease Control and Prevention

CAPT Jennifer Wiltz, MD, MPH, FAAP, FAHA (USPHS)
Clinical Task Force Deputy, 2019 CDC EVALI Response
Senior Medical Officer, Division for Heart Disease and Stroke Prevention
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention


Title:Update: Interim Guidance for Health Care Providers Evaluating and Caring for Patients with Suspected E-cigarette or Vaping Product Use Associated Lung Injury

Date:Thursday, October 17, 2019

During this COCA Call, clinicians will learn about updates to prior interim recommendations for U.S. health care providers caring for patients with suspected or known lung injury associated with e-cigarette or vaping products as published in MMWR on October 11, 2019.

Presenters

Lieutenant Commander David Siegel, MD, MPH (USPHS)
Clinical Team, 2019 CDC Lung Injury Emergency Response
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention


Title:Outbreak of Lung Injury Associated with E-cigarette Product Use or Vaping: Information for Clinicians

Date:Thursday, September 19, 2019

CDC will review e-cigarette and vaping terminology, clinical features reported among cases of lung injury in recent outbreaks, and CDC recommendations for clinicians.

Presenters

Lieutenant Commander Tara Jatlaoui, MD, MPH (USPHS)
Medical Officer, Medical Epidemiologist
Clinical Team Lead, 2019 CDC Lung Injury Response
National Center for Chronic Disease Prevention and Health Promotion
Centers for Disease Control and Prevention

Page last reviewed: December 2, 2016